SG10201801956SA - Antimicrobial compounds and methods of making and using the same - Google Patents
Antimicrobial compounds and methods of making and using the sameInfo
- Publication number
- SG10201801956SA SG10201801956SA SG10201801956SA SG10201801956SA SG10201801956SA SG 10201801956S A SG10201801956S A SG 10201801956SA SG 10201801956S A SG10201801956S A SG 10201801956SA SG 10201801956S A SG10201801956S A SG 10201801956SA SG 10201801956S A SG10201801956S A SG 10201801956SA
- Authority
- SG
- Singapore
- Prior art keywords
- making
- methods
- same
- antimicrobial compounds
- antimicrobial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361875643P | 2013-09-09 | 2013-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201801956SA true SG10201801956SA (en) | 2018-04-27 |
Family
ID=52629046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201801956SA SG10201801956SA (en) | 2013-09-09 | 2014-09-09 | Antimicrobial compounds and methods of making and using the same |
| SG11201601654TA SG11201601654TA (en) | 2013-09-09 | 2014-09-09 | Antimicrobial compunds and methods of making and using the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601654TA SG11201601654TA (en) | 2013-09-09 | 2014-09-09 | Antimicrobial compunds and methods of making and using the same |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10106543B2 (de) |
| EP (1) | EP3039025A4 (de) |
| JP (1) | JP2016536338A (de) |
| KR (1) | KR20160070066A (de) |
| CN (1) | CN106103442A (de) |
| AU (1) | AU2014315050A1 (de) |
| CA (1) | CA2923214A1 (de) |
| IL (1) | IL244416A0 (de) |
| MX (1) | MX2016002975A (de) |
| PH (1) | PH12016500453A1 (de) |
| SG (2) | SG10201801956SA (de) |
| WO (1) | WO2015035426A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011047320A2 (en) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| CN102725274A (zh) | 2009-10-16 | 2012-10-10 | Rib-X制药公司 | 抗微生物化合物和其制备和使用方法 |
| JO3078B1 (ar) | 2009-11-27 | 2017-03-15 | Janssen Pharmaceutica Nv | مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة |
| AU2014315050A1 (en) | 2013-09-09 | 2016-03-24 | Melinta Therapeutics, Inc. | Antimicrobial compunds and methods of making and using the same |
| JP2016529325A (ja) | 2013-09-09 | 2016-09-23 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物化合物ならびにそれの製造方法および使用方法 |
| MX2017011616A (es) | 2015-03-11 | 2018-04-11 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos para hacerlos y usarlos. |
| WO2017193023A1 (en) * | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
| CA3023444A1 (en) * | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
| US11098047B2 (en) * | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
| US20210403473A1 (en) * | 2018-02-21 | 2021-12-30 | BioVersys AG | Antimicrobial compounds and methods of making and using the same |
| WO2019234508A1 (en) | 2018-06-06 | 2019-12-12 | BioVersys AG | Biodefense agents |
| WO2019234509A2 (en) * | 2018-06-06 | 2019-12-12 | BioVersys AG | Aminomethylamidine and methylamidine antimicrobial compounds |
| WO2020115547A2 (en) * | 2018-12-07 | 2020-06-11 | BioVersys AG | Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds |
| CA3158103A1 (en) * | 2019-11-13 | 2021-05-20 | Curza Global, Llc | Antimicrobial compounds and methods |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2624731A (en) | 1953-01-06 | S-phenylpyrimidkn e x derivativesx | ||
| US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
| US3673184A (en) | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
| US4361557A (en) | 1980-01-28 | 1982-11-30 | Schering Corporation | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor |
| EP0067610A1 (de) | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Penicilline, ein Verfahren zu ihrer Herstellung und sie enthaltende Zusammensetzungen |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5332835A (en) | 1984-02-03 | 1994-07-26 | Zambon S.P.A. | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process |
| JPS6191184A (ja) | 1984-10-08 | 1986-05-09 | Morishita Seiyaku Kk | ２−アニリノ−５−（１ｈ−テトラゾ−ル−５−イル）ピリミジン−４（３ｈ）−オン誘導体 |
| JP2873340B2 (ja) | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| JP2991382B2 (ja) | 1990-07-18 | 1999-12-20 | 大日本製薬株式会社 | 縮合三環式化合物およびその塩 |
| US5208141A (en) | 1990-10-09 | 1993-05-04 | Konica Corporation | Silver halide color photographic light-sensitive material |
| US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| US6451968B1 (en) | 1991-05-24 | 2002-09-17 | Isis Pharmaceuticals, Inc. | Peptide nucleic acids |
| US5766855A (en) | 1991-05-24 | 1998-06-16 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity and sequence specificity |
| US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
| US5646163A (en) | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| PL174704B1 (pl) | 1993-05-12 | 1998-09-30 | Du Pont | Nowe 4(3H)-chinazolinony i środek grzybobójczy do zwalczania mączniaka pszenicy |
| US5502177A (en) | 1993-09-17 | 1996-03-26 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
| US5567884A (en) | 1994-03-09 | 1996-10-22 | International Business Machines Corporation | Circuit board assembly torsion tester and method |
| US5668127A (en) | 1995-06-26 | 1997-09-16 | Pathogenesis Corporation | Nitroimidazole antibacterial compounds and methods of use thereof |
| TW424090B (en) | 1995-08-18 | 2001-03-01 | Nat Science Council | Pyrimidines as folate antimetabolites with selective activity against human brain cancer |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US7282327B2 (en) | 1996-01-23 | 2007-10-16 | Affymetrix, Inc. | Nucleic acid labeling compounds |
| GB9708611D0 (en) | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
| US6110925A (en) | 1997-08-07 | 2000-08-29 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
| US6028183A (en) | 1997-11-07 | 2000-02-22 | Gilead Sciences, Inc. | Pyrimidine derivatives and oligonucleotides containing same |
| CA2309340C (en) | 1997-11-07 | 2006-02-21 | Isis Pharmaceuticals Inc. | Pyrimidine derivatives for labeled binding partners |
| DE19838998A1 (de) | 1998-08-27 | 2000-03-09 | Bayer Ag | Neue Naturstoffderivate |
| SE9903894D0 (sv) | 1999-10-28 | 1999-10-28 | New Pharma Research Ab | Novel compounds |
| EP1113008A1 (de) | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-Oxo-2-Ureido-1,4,5,6-Tetrahydropyrimidinderivate als Antibakterielle und Antiprotozoen Mittel |
| KR100358083B1 (ko) | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
| CN1646141B (zh) | 2000-10-18 | 2014-06-25 | 吉利德制药有限责任公司 | 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 |
| DE10061542A1 (de) | 2000-12-11 | 2002-06-13 | Bayer Ag | Alkanoylamino-pyrimidine |
| DE10061537A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | beta-Alanin-Derivate |
| DE10061541A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Arylamino-Dihydropyrimidinone |
| DE10061538A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Ureido-Dihydropyrimidinone |
| AU3089102A (en) | 2000-12-14 | 2002-06-24 | Procter & Gamble | Antimicrobial quinolones |
| US6900215B2 (en) | 2000-12-15 | 2005-05-31 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| EP1363640B1 (de) | 2001-01-29 | 2010-04-28 | Bio-Rad Laboratories, Inc. | Nukleinsäurederivative |
| TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| US20030207804A1 (en) | 2001-05-25 | 2003-11-06 | Muthiah Manoharan | Modified peptide nucleic acids |
| US20030158403A1 (en) | 2001-07-03 | 2003-08-21 | Isis Pharmaceuticals, Inc. | Nuclease resistant chimeric oligonucleotides |
| JP2005504020A (ja) | 2001-07-03 | 2005-02-10 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヌクレアーゼ耐性キメラオリゴヌクレオチド |
| DE10133277A1 (de) | 2001-07-09 | 2003-01-23 | Bayer Ag | ß-Alanin-Derivate |
| DE10141271A1 (de) | 2001-08-23 | 2003-03-06 | Bayer Ag | Neue Tetrahydro-1,3,5-triazin-2-on-Derivate und ihre Verwendung |
| DE10208256A1 (de) | 2002-02-26 | 2003-09-04 | Bayer Ag | Piperidinouracile |
| WO2003077828A2 (en) | 2002-03-08 | 2003-09-25 | Schering-Plough, Ltd. | Novel florfenicol-type antibiotics |
| WO2004080466A1 (en) | 2003-03-07 | 2004-09-23 | Ribapharm Inc. | Cytidine analogs and methods of use |
| KR20060069836A (ko) | 2003-08-12 | 2006-06-22 | 아칠리온 파르마세우티칼스 인코포레이티드 | 항-감염제로서의 이소티아졸로퀴놀론 및 관련 화합물 |
| MXPA06002001A (es) | 2003-08-26 | 2006-06-20 | Teijin Pharma Ltd | Derivados pirrolopirimidinona. |
| TW200524880A (en) | 2003-10-21 | 2005-08-01 | Sankyo Co | Pyrimidine compounds |
| EP1781788A2 (de) | 2004-06-30 | 2007-05-09 | ZGene A/S | Desoxycytidinkinase- und desoxyadenosinkinase-enzyme aus huhn und deren verwendung |
| ATE482219T1 (de) | 2005-07-27 | 2010-10-15 | Achillion Pharmaceuticals Inc | 8-methoxy-9h-isothiazoloä5,4-büchinolin-3,4-dio e und verwandte verbindungen als antiinfektive mittel |
| CN101360720A (zh) | 2005-11-15 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | 新颖的2-氨基嘧啶酮衍生物及其用途 |
| NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| JP2007270087A (ja) | 2006-03-31 | 2007-10-18 | Fujifilm Corp | 硬化性組成物、インク組成物、インクジェット記録方法、印刷物、平版印刷版の製造方法、及び平版印刷版 |
| ATE496766T1 (de) | 2006-03-03 | 2011-02-15 | Fujifilm Corp | Härtbare zusammensetzung, tintenzusammensetzung, tintenstrahlaufzeichnungsverfahren und flachdruckplatte |
| KR20080003599A (ko) | 2006-07-03 | 2008-01-08 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법 |
| AU2007270276A1 (en) | 2006-07-03 | 2008-01-10 | Sk Chemicals Co., Ltd. | Salts of pyrrolopyrimidinone derivatives and process for preparing the same |
| US20100112561A1 (en) | 2006-08-25 | 2010-05-06 | Stefan Lutz | Fluorescent nucleoside analogues |
| AU2007293774C1 (en) | 2006-09-07 | 2014-12-18 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| EP1964841A1 (de) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]azine und deren pharmazeutische Verwendung |
| WO2008143729A2 (en) | 2007-02-28 | 2008-11-27 | Rib-X Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
| US20080221094A1 (en) | 2007-03-07 | 2008-09-11 | Harald Bluhm | Metalloprotease inhibitors containing a squaramide moiety |
| JP2008222557A (ja) | 2007-03-08 | 2008-09-25 | Kotobuki Seiyaku Kk | ピロロ［３，２−ｄ］ピリミジン誘導体及びこれを有効成分とする医薬組成物 |
| PE20090758A1 (es) | 2007-05-30 | 2009-06-24 | Schering Plough Ltd | Un proceso para la preparacion de compuestos de aminodiol protegidos con oxazolina, utiles como intermediarios para florfenicol |
| TWI519508B (zh) | 2007-06-12 | 2016-02-01 | Achaogen Inc | 抗菌劑 |
| US20110046142A1 (en) | 2007-06-13 | 2011-02-24 | Northeastern University | Antibiotic compounds |
| GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| KR20090098710A (ko) | 2008-03-14 | 2009-09-17 | 주식회사 씨티아이바이오 | 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체 |
| WO2010087467A1 (en) | 2009-01-27 | 2010-08-05 | Takeda Pharmaceutical Company Limited | Delta-5-desaturase inhibitors |
| WO2011017319A1 (en) | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating disorders associated with protein polymerization |
| EP2501696B1 (de) | 2009-10-15 | 2016-12-28 | Guerbet | Kontrastmittel und ihre verwendung zur in-vivo-diagnose von neurodegenerativen erkrankungen, im besonderen morbus alzheimer und daraus resultierende erkrankungen |
| TW201726630A (zh) | 2009-10-16 | 2017-08-01 | 梅林塔療法公司 | 抗微生物性化合物及其製造與使用方法 |
| CN102725274A (zh) | 2009-10-16 | 2012-10-10 | Rib-X制药公司 | 抗微生物化合物和其制备和使用方法 |
| KR101972992B1 (ko) | 2009-10-16 | 2019-04-29 | 멜린타 서브시디어리 코프. | 항미생물성 화합물 및 이의 제조 방법 및 사용 방법 |
| WO2011047320A2 (en) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| WO2012125832A2 (en) | 2011-03-15 | 2012-09-20 | Rib-X Pharmaceuticals, Inc. | Antimicrobial agents |
| CA2833169A1 (en) * | 2011-04-15 | 2012-12-20 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| JP2016529325A (ja) | 2013-09-09 | 2016-09-23 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物化合物ならびにそれの製造方法および使用方法 |
| AU2014315050A1 (en) | 2013-09-09 | 2016-03-24 | Melinta Therapeutics, Inc. | Antimicrobial compunds and methods of making and using the same |
| FR3014513B1 (fr) * | 2013-12-09 | 2017-04-28 | Chassis Brakes Int Bv | Frein a tambour muni d'un organe de retenue d'un segment de freinage. |
| MX2017011616A (es) | 2015-03-11 | 2018-04-11 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos para hacerlos y usarlos. |
-
2014
- 2014-09-09 AU AU2014315050A patent/AU2014315050A1/en not_active Abandoned
- 2014-09-09 US US14/917,921 patent/US10106543B2/en active Active
- 2014-09-09 JP JP2016540938A patent/JP2016536338A/ja active Pending
- 2014-09-09 MX MX2016002975A patent/MX2016002975A/es unknown
- 2014-09-09 EP EP14841546.6A patent/EP3039025A4/de not_active Withdrawn
- 2014-09-09 SG SG10201801956SA patent/SG10201801956SA/en unknown
- 2014-09-09 CN CN201480061342.2A patent/CN106103442A/zh active Pending
- 2014-09-09 CA CA2923214A patent/CA2923214A1/en not_active Abandoned
- 2014-09-09 WO PCT/US2014/054869 patent/WO2015035426A1/en active Application Filing
- 2014-09-09 SG SG11201601654TA patent/SG11201601654TA/en unknown
- 2014-09-09 KR KR1020167009319A patent/KR20160070066A/ko not_active Application Discontinuation
-
2016
- 2016-03-03 IL IL244416A patent/IL244416A0/en unknown
- 2016-03-09 PH PH12016500453A patent/PH12016500453A1/en unknown
-
2018
- 2018-10-18 US US16/163,822 patent/US10815238B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201601654TA (en) | 2016-04-28 |
| US20190284190A1 (en) | 2019-09-19 |
| US10815238B2 (en) | 2020-10-27 |
| MX2016002975A (es) | 2016-10-21 |
| CA2923214A1 (en) | 2015-03-12 |
| US20160214988A1 (en) | 2016-07-28 |
| KR20160070066A (ko) | 2016-06-17 |
| CN106103442A (zh) | 2016-11-09 |
| EP3039025A1 (de) | 2016-07-06 |
| EP3039025A4 (de) | 2017-05-31 |
| JP2016536338A (ja) | 2016-11-24 |
| AU2014315050A1 (en) | 2016-03-24 |
| US10106543B2 (en) | 2018-10-23 |
| PH12016500453A1 (en) | 2016-05-16 |
| WO2015035426A1 (en) | 2015-03-12 |
| IL244416A0 (en) | 2016-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| HK1226056A1 (zh) | 吡唑並化合物及其用途 | |
| HK1249758A1 (zh) | 抗微生物化合物及其製備和使用方法 | |
| ZA201603549B (en) | New pesticidal compounds and uses | |
| IL244416A0 (en) | Antimicrobial compounds and methods for their preparation and use | |
| HK1214171A1 (zh) | 賽尼克韋羅組合物及其製備和使用方法 | |
| IL265876A (en) | Preparations that include 15-ohepa and methods of using them | |
| EP2991658A4 (de) | Antimikrobielle zusammensetzungen und verfahren zur herstellung davon | |
| EP3038623A4 (de) | Antimikrobielle verbindungen und verfahren zur herstellung und verwendung davon | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| EP3054974A4 (de) | Glycaninteragierende verbindungen und verfahren zur verwendung | |
| GB201312318D0 (en) | Novel methods and compounds | |
| GB201300707D0 (en) | Compounds and processes | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| HK1223307A1 (zh) | 新型化合物和其用途 | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| GB201320161D0 (en) | Compounds and their uses | |
| GB201313605D0 (en) | Novel compounds and their use | |
| GB201323005D0 (en) | Compounds and uses thereof | |
| GB201309248D0 (en) | Compounds and combinations | |
| GB201307202D0 (en) | New compounds and uses | |
| GB201307201D0 (en) | New compounds and uses | |
| GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same |